It should be noted that 50 healthcare organizations from 27 regions participated in the study.
“We were interested in general information about the medical organization necessary for calculating the indicators, information about patients without personalization, information about the medical technologies used that may be accompanied by a risk of infection, laboratory data, results of radiation, endoscopic studies, etc., as well as clinical symptoms of infection and data from microbiological studies with the results of determining sensitivity to antibiotics,” Deputy Director for Scientific Work at the Institute of Public Health named after FF University Erisman Sechenov, Chief Freelance Epidemiologist of the Ministry of Health Roman Polibin told RG.
According to him, the study will help develop effective measures to prevent the spread of nosocomial infections and obtain new data on the effectiveness of antibacterial drugs. Scientists plan to find out which antibiotics pathogenic microorganisms have become resistant to, he explained.
Nosocomial infections, meanwhile, include microbial diseases that patients or doctors contract in medical institutions. These could be, for example, purulent intestinal or septic infections, as well as diseases transmitted by airborne droplets: measles, influenza, rubella.
